AT2 receptor agonists: Hypertension and beyond

Current Opinion in Nephrology and Hypertension

Volumn 21, Issue 2, 2012, Pages 142-146

  Steckelings, Ulrike M ^a   Paulis, Ludovit ^a   Namsolleck, Pawel ^a   Unger, Thomas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

AT2 receptor; AT2 receptor agonists; renin angiotensin system

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; LOSARTAN; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; NITRIC OXIDE; OLMESARTAN;

ALZHEIMER DISEASE; HEART INFARCTION; HUMAN; HYPERTENSION; IN VIVO STUDY; KIDNEY DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; PULSE WAVE; REVIEW; SIGNAL TRANSDUCTION; STROKE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD VESSELS; BRAIN ISCHEMIA; COGNITION; HYPERTENSION; INFLAMMATION; KIDNEY DISEASES; MYOCARDIAL INFARCTION; RECEPTOR, ANGIOTENSIN, TYPE 2; SIGNAL TRANSDUCTION;

EID: 84857050578     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e328350261b     Document Type: Review

References (19)

1. Tigerstedt R, Bergmann P. Niere und Kreislauf. Skand Arch Physiol 1898; 8:223-271.
2. Steckelings UM, Unger T. The renin-Angiotensin-Aldosterone system. In: Manual of hypertension of the European Society of Hypertension. London: Informa Healthcare; 2008: Pp. 110-116.
3. Iwai M, Horiuchi M. Devil and angel in the renin-Angiotensin system: ACEangiotensin II-AT1 receptor axis vs. ACE2-Angiotensin-(1-7)-Mas receptor axis. Hypertens Res 2009; 32:533-536.
4. Katovich MJ, Grobe JL, Raizada MK. Angiotensin-(1-7) as an antihypertensive, antifibrotic target. Curr Hypertens Rep 2008; 10:227-232.
5. Steckelings UM, Larhed M, Hallberg A, et al. Nonpeptide AT2-receptor agonists. Curr Opin Pharmacol 2011; 11:187-192.
6. Whitebread S, Mele M, Kamber B, de Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989; 163:284-291. (Pubitemid 19227303)
7. Wan Y, Wallinder C, Plouffe B, et al. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J Med Chem 2004; 47:5995-6008. (Pubitemid 39507341)
8. Bosnyak S, Welungoda IK, Hallberg A, et al. Stimulation of angiotensin AT2 receptors by the nonpeptide agonist, compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats. Br J Pharmacol 2010; 159:709-716. Detailed study looking at in-vivo and ex-vivo effects of C21 on vasodilation and BP regulation.
9. Gelosa P, Pignieri A, Fä ndriks L, et al. Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: Focus on renal damage. J Hypertens 2009; 27:2444-2451.
10. Matavelli LC, Huang J, Siragy HM. Angiotensin AT2 receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension 2011; 57:308-313. Study looking at acute effects of AT2R stimulation in renal disease.
11. Paulis L, Becker ST, Lucht K, et al. Direct AT2 receptor stimulation in L-NAMEinduced hypertension: The effect on pulse wave velocity and aortic remodeling. Hypertension 2012. [Epub ahead of print] Study looking at the effect of AT2R stimulation on hypertension-induced vascular remodelling including measurement of pulse wave velocity.
12. Rehmann A, Leibovitz A, Yamamoto N, et al. Angiotensin type 2 receptor agonist C21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension 2011. [Epub ahead of print] Study looking at the effect of AT2R stimulation on hypertension-induced vascular remodelling.
13. Li XC, Widdop RE. AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR. Br J Pharmacol 2004; 142:821-830. (Pubitemid 38998096)
14. Kaschina E, Grzesiak A, Li J, et al. Angiotensin II type 2 receptor stimulation: A novel option of therapeutic interference with the renin-Angiotensin system in myocardial infarction? Circulation 2008; 118:2523-2532.
15. Joseph JP, Regenhardt RW, Mecca AP, et al. Central and peripheral administration of compound 21 elicits cerebroprotective effects in ischemic stroke [abstract]. In: Abstracts from Experimental Biology 2011 Meeting; Washington, DC. FASEB J 2011; 25: Lb576.
16. Schwengel, Katja, Thöne-Reineke, et al. Direct AT2-receptor stimulation improves survival and neurological outcome after experimental stroke (MCAO) in mice [abstract]. In: Abstract from the 15th meeting of the European Council for Cardiovascular Research; 1 December 2010; Nice, France. Hypertension; 2010; 56:1161.
17. Jing F, Mogi M, Sakata A, et al. Direct stimulation of angiotensin II type 2 receptor enhances spatial memory. J Cereb Blood Flow Metab 2011. doi:10.1038/jcbfm.2011.133. [Epub ahead of print] Study looking at the effect of AT2R stimulation on cognitive function.
18. Rompe F, Artuc M, Hallberg A, et al. Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB. Hypertension 2010; 55:924-931. Study looking at antiinflammatory mechanisms of AT2R stimulation.
19. Rompe F, Unger T, Steckelings UM. The angiotensin AT2 receptor in inflammation. Drug News Perspect 2010; 23:104-111.